In the present study, the increase in plasma IgE in mice with experimental AD was not reduced by the topical treatment with either Dex, Dex-TBZ, Dex-ADT, TBZ, or ADT-OH, which may be a consequence of the short-term treatment. The gene discussed is IGHE; the disease is Alzheimer disease.